21 articles for SD Kattar
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease.
Merck
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors.
Merck
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.
Merck
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow.
Merck
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability.
TBA
Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.
Merck Research Laboratories
AMP-activated protein kinase inhibitors and methods of making and using the same
University Of Colorado
HETEROBIFUNCTIONAL TARGETED PROTEIN DEGRADERS
St. Jude Children'S Research Hospital
ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
Gilgamesh Pharmaceuticals
Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof
East China University of Science and Technology
Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use
Merck Sharp & Dohme
Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase
Bristol-Myers Squibb
Design, Synthesis, Structural Characterization by IR, (1) H, (13) C, (15) N, 2D-NMR, X-Ray Diffraction and Evaluation of a New Class of Phenylaminoacetic Acid Benzylidene Hydrazines as pfENR Inhibitors.
Bombay College of Pharmacy